![Page 1: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/1.jpg)
CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONSTHE PHILADELPHIA CYBERKNIFE CENTER
EXPERIENCE
Olusola Obayomi-Davies M.D.Philadelphia CyberKnife Center
September 26th, 2017
![Page 2: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/2.jpg)
Disclosure & Disclaimer
• An honorarium is provided by Accuray for this presentation
• The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of Accuray Incorporated or its subsidiaries. No official endorsement by Accuray Incorporated or any of its subsidiaries of any vendor, products or services contained in this presentation is intended or should be inferred.
![Page 3: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/3.jpg)
Background-Localized Prostate Cancer• Estimated 160,000 men will be affected in
2017– 27,000 deaths– #1 cancer diagnosis in men– #3 cause of cancer related mortality
• Typically detected by PSA screening– USPSTF D-Recommendation (2012)– C Recommendation 2017 (55-69)
Cancer Facts & Figures ACS 2017Screening for Prostate Cancer: U.S. Preventive Services Task ForceRecommendation Statement, 2012, 2017.
![Page 4: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/4.jpg)
Treatment Options-Localized Prostate Cancer
• Surgery-Prostatectomy• Radiation Therapy
– IMRT Conventional Fractionation (40-48)– IMRT Moderate Hypofractionation (20-28)– Proton Therapy – Brachytherapy
• HDR or LDR
– CyberKnife SBRT (5 treatments)
![Page 5: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/5.jpg)
N Engl J Med 2016;375:1415-24
• 1643 men (50-69) randomized to AS, Surgery or Radiation therapy between 1999-2009.
• Primary outcome: Prostate cancer specific mortality at 10 years
The New England Journal of MedicineOctober 13, 2016 Vol. 375 No. 15
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
F.C. Hamdy, J.L. Donovan, J.A. Lane, M. Mason, C. Metcalfe, P. Holding, M. Davis, T.J. Peters, E.L. Turner
![Page 6: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/6.jpg)
N Engl J Med 2016;375:1415-24
The New England Journal of MedicineOctober 13, 2016 Vol. 375 No. 15
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer
F.C. Hamdy, J.L. Donovan, J.A. Lane, M. Mason, C. Metcalfe, P. Holding, M. Davis, T.J. Peters, E.L. Turner
![Page 7: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/7.jpg)
IMRT-Localized Prostate Cancer• Daily radiation therapy for 8-9
weeks (40-48)• Hypofractionated regimen
(20-38) fractions• Rectal and Bladder sparing• Significant dose escalation
from 3D-CRT• Popular, high penetration in
radiation oncology community• Effective
Sveistrup et al. Radiation Oncology 2014, 9:44
![Page 8: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/8.jpg)
External Beam Radiation5yr BDFSLow 95%Inter. 82%High 62%
• 1988-2004, 2047 patients 3D or IMRT (1996)• 66-86.4 Gy in 33-48 fractions.
Zelefsky, Int. J. Radiation Oncology Biol. Phys., Vol. 71, No. 4, pp. 1028–1033, 2008
![Page 9: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/9.jpg)
IMRT-81 Gy
• 1996-2000, 561 patients• 81 Gy • Low rates of rectal and urinary toxicity
Zelefsky, J. Urology Vol. 176, 1415-1419, October 2006
8yr BRFSFavorable 85%Intermediate 76%Unfavorable 72%
![Page 10: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/10.jpg)
IMRT-For Localized Prostate Cancer: Concerns
• Radiation Dose: Is 80-86 Gy high enough? – Further dose escalation required?
• Normal Structures: – Bowel, Bladder
• Opportunity cost:– 8-9 weeks of daily therapy
• Other:– Prostate motion, rectal and bladder filling
![Page 11: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/11.jpg)
CyberKnife® SBRT-Rationale
• Radiobiology: Low αβ ratio of prostate cancer– Favors larger fractionation schemes
• Normal Structure sparing– Rectum, Bladder, Penile bulb
• Opportunity cost: 5 days versus 8-9 weeks of treatment
• Technology: Prostate motion management
![Page 12: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/12.jpg)
CyberKnife® Prostate SBRT Rationale: αβ ratio
(2 Gy x 37 fx)bNED (5 year) 75%
SBRT (7.25 Gy x 5 fx)bNED (5 year), 94%
Fowler, Acta Oncol, 2005
![Page 13: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/13.jpg)
CyberKnife® SBRT: αβ ratio
Wallace, Radiation Biology 2014
![Page 14: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/14.jpg)
Prostate Motion: Where is the target?
Kupelian et al, IJROBP, 2007
![Page 15: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/15.jpg)
CyberKnife® SBRT For Localized Prostate Cancer: Overview
• Robotic Radiosurgery Platform
• Deliver high dose radiation in 5 treatments– ≥8 weeks of daily radiation
equivalent
• Sparing of normal Structures from high dose radiation– 3-5mm margins
• Live target tracking with gold fiducials
CyberKnife.com, accessed 7/2017
![Page 16: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/16.jpg)
CyberKnife® SBRT For Localized Prostate Cancer
Chen L. et al Rad. Onc., 2013
![Page 17: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/17.jpg)
CyberKnife® SBRT-Concerns
• Long term data maturing
• Few prospective comparisons to more established techniques
• Concerns about late bladder and GU toxicity
• Healthcare Costs: Shrinking healthcare $$
![Page 18: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/18.jpg)
Published Prostate SBRT Series
![Page 19: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/19.jpg)
• 515 patients between 2006-2010 treated with CyberKnife® SBRT, 35-36.25 Gy, daily.
• NCCN Risk Stratification– Low risk-324– Intermediate risk-153– High Risk-38
• Median Follow-up 84 months
Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and
Patterns of FailureAlan Katz, Silvia C. Formenti and Josephine Kang
![Page 20: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/20.jpg)
Katz A, (2016) Front. Oncol. 6:168
Predicting Biochemical Disease-Free Survival after Prostate Stereotactic Body Radiotherapy: Risk-Stratification and
Patterns of FailureAlan Katz, Silvia C. Formenti and Josephine Kang
![Page 21: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/21.jpg)
Prostate SBRT: Quality of Life
• Urinary quality of life
• Bowel quality of life
• Sexual Function
![Page 22: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/22.jpg)
Prostate SBRT QOL: GI/GU Toxicity
Meier, R. Front. Oncol, 2015
![Page 23: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/23.jpg)
Prostate SBRT QOL: GI/GU Toxicity
Meier, R. Front. Oncol, 2015
![Page 24: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/24.jpg)
Prostate SBRT QOL: GU/ED
Meier, R. Front. Oncol, 2015
![Page 25: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/25.jpg)
• 97 Hormone naive men (aged 48-82)• Adequate erectile function pre-treatment
– Firm enough for penetration
• 35-36.25 Gy in 5 fractions• Minimum 24 month follow-up• Assessments: SHIM, EPIC and
Medication/Device Questionaires
Obayomi-Davies et al. Radiation Oncology 2013, 8:256
Potency preservation following stereotactic body radiation therapy for prostate cancer
Olusola Obayomi-Davies, Leonard N Chen, Aditi Bhagat, Henry C Wright, Sunghae Uhm, Joy S Kim, Thomas M Yung, Siyuan Lei, Gerald P Batipps, John Pahira, Kevin G McGeagh, Brian T Collins, Keith Kowalczyk, Gaurav Bandi, Deepak Kumar, Simeng Suy, Anatoly Dritschilo, John H Lynch, Sean P Collins
![Page 26: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/26.jpg)
Obayomi-Davies et al. Radiation Oncology 2013, 8:256
Potency preservation following stereotactic body radiation therapy for prostate cancer
Olusola Obayomi-Davies, Leonard N Chen, Aditi Bhagat, Henry C Wright, Sunghae Uhm, Joy S Kim, et al.
![Page 27: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/27.jpg)
The Philadelphia CyberKnife Experience
• First CyberKnife®
System facility in Philadelphia region
• Opened in 2006• Pioneers
– Luther Brady/Jack Fowler
– Rachelle Lanciano– John Lamond
![Page 28: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/28.jpg)
• 100 consecutive patients with NCCN intermediate or highrisk prostate cancer treated with definitive SBRT wereidentified.
• Patients with <2 years biochemical follow-up were excluded(n=26).
• Biochemical failure was defined as prostate-specific antigen(PSA) rise > 2ng/ml above nadir (Phoenix definition)
• Analyses performed using the Kaplan Meier method, withdifferences compared using log-rank test.
Stereotactic Body Radiation Therapy for Treatment of Intermediate-and High-Risk Prostate CancerMark Dziemianowicz MD, Rachelle Lanciano MD, Olusola Obayomi-Davies MD, Steven Arrigo MD, John Lamond, MD, Jun Yang PhD, Jing Feng MS, Michael Mooreville MD, Bruce Garber MD, Michael Good, Luther Brady MD.Philadelphia CyberKnife, Havertown, PA
![Page 29: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/29.jpg)
• Risk classification: Zumsteg et al. criteria for favorable intermediate-risk (FIR) and unfavorable intermediate risk (UIR) disease– FIR: NCCN intermediate risk with a single NCCN intermediate
risk factor(cT2b-c, PSA 10-20 or Gleason score 7), Gleason < 3+4, and <50% of biopsy cores positive for cancer
– UIR: NCCN intermediate risk with ≥2 intermediate risk factors (cT2b-c, PSA 10-20 or Gleason score 7), primary Gleason pattern 4, or >50% biopsy cores positive for cancer
– High risk (HR) patients classified per NCCN guidelines
Zumsteg et al. Eur Urol Dec;64(6):895-902
Stereotactic Body Radiation Therapy for Treatment of Intermediate-and High-Risk Prostate CancerMark Dziemianowicz MD, Rachelle Lanciano MD, Olusola Obayomi-Davies MD, Steven Arrigo MD, John Lamond, MD, Jun Yang PhD, Jing Feng MS, Michael Mooreville MD, Bruce Garber MD, Michael Good, Luther Brady MD.Philadelphia CyberKnife, Havertown, PA
![Page 30: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/30.jpg)
Philadelphia CyberKnife: Treatment Planning• All patients received
CyberKnife® SBRT
• Dose: 35-37.5 Gy/5 fractions
• CTV: Defined as prostate plus seminal vesicles
• PTV: 5mm, 3mm posteriorly– (Now 3mm superiorly)
![Page 31: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/31.jpg)
Philadelphia CyberKnife: Results
![Page 32: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/32.jpg)
Philadelphia CyberKnife: Results
5yr bRFSFIR-100%, p=0.007UIR-83.3%, p=0.07HR-92.3%
5yr OSFIR-96.2%, p=0.08UIR-71.4%, p=0.52HR-89.5%
• 5-year bRFS: 89.7%• 5 failures: 3 distant, 2 biochemical only
• 5-year OS: 87.3%• 7 deaths: none caused by prostate cancer
0
0.2
0.4
0.6
0.8
1
0 1 2 3 4 5 6 7 8
PSA
bRFS
Time (years)Number at risk
74 51 40 27 13 8
0
0.2
0.4
0.6
0.8
1
0 1 2 3 4 5 6 7 8
Ove
rall
Surv
ival
Time (years)
![Page 33: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/33.jpg)
Philadelphia CyberKnife: Results
00.10.20.30.40.50.60.70.80.9
1
0 1 2 3 4 5 6 7 8
PSA
bRFS
Time (years)
4+3
≤3+4
≥4+4
Log-rank p=0.0195-year bRFS< 3+4 100%4+3 75%> 4+4 80%
![Page 34: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/34.jpg)
Philadelphia CyberKnife: Results
0
0.2
0.4
0.6
0.8
1
0 1 2 3 4 5 6 7 8
PSA
bRFS
Time (years)
ADT
NoADT
Number at riskADT 24 18 16 12 4 2 No ADT 50 33 24 15 9 6
Log-rank p=0.403
5-year BRFSADT 100%No ADT 83.4%
Patients receiving ADT n (%)FIR 13 (37.1%)UIR 3 (17.6%)HR 8 (36.4%)
![Page 35: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/35.jpg)
Philadelphia CyberKnife: ToxicityN=74 %
Late GU ToxicityGrade 1 10 14%Grade 2 19 26%Grade 3 1 1%Grade 4 0 0%
Late GI ToxicityGrade 1 2 3%Grade 2 0 0%Grade 3 0 0%Grade 4 0 0%
Late Erectile DysfunctionGrade 1 15 20%Grade 2 24 32%Grade 3 8 11%
![Page 36: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/36.jpg)
Front. Oncol., 23 August 2016
The Comparison of Stereotactic Body Radiation Therapy and Intensity-Modulated Radiation Therapy for Prostate
Cancer by NCCN Risk GroupsAnthony Ricco,1 Genevieve Manahan,1,2 Rachelle Lanciano,1,2,* Alexandra Hanlon,3 Jun Yang,1,2 Stephen Arrigo,1John Lamond,1,2 Jing Feng,1 Michael Mooreville,1 Bruce Garber,1 and Luther Brady1,2
1Philadelphia Cyberknife, Delaware County Memorial Hospital, Havertown, PA, USA 2Drexel University College of Medicine, Philadelphia, PA, USA 3University of Pennsylvania, Philadelphia, PA, USA
![Page 37: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/37.jpg)
Philadelphia CyberKnife Experience• Between 2007 and 2012, 270 consecutive men were treated for
organ confined prostate cancer with either IMRT (n=120) or SBRT (n=150)
• Charts were abstracted for pretreatment and treatment factors as well as outcome and toxicity
• NCCN Risk Group Guidelines V. 2.2015 were used to stratify patients into Very Low, Low, Intermediate, High and Very High risk groups.
• Dose: – IMRT: 75.6-78 Gy in 39-42 fractions– SBRT: 36.25-37.5 Gy in 5 fractions
![Page 38: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/38.jpg)
Philadelphia CyberKnife Experience• Late toxicity was graded by RTOG grading system at last
follow up
• Nadir +2 considered Biochemical failure
• Statistical analysis included Fisher’s Exact Test and Two-Sample Independent T-Test for comparison of pretreatment factor distribution between IMRT and SBRT, Kaplan Meier for comparison of curves
• Propensity Score matched comparison
![Page 39: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/39.jpg)
Philadelphia CyberKnife Experience
6-year FFBF 91.9% for SBRT88.9% for IMRT
![Page 40: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/40.jpg)
Philadelphia CyberKnife Experience
![Page 41: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/41.jpg)
Ricco et al, Front. Oncol. August 2017
• Propensity score matched (PSM) analysis with the National Cancer Database (NCDB) for the comparison of stereotactic body radiation therapy (SBRT) and intensity modulated radiation therapy (IMRT) for organ confined prostate cancer
• Men with localized prostate cancer treated with IMRT to a dose ≥72 Gy and ≥35 Gy for SBRT to the prostate only
• Men treated with previous surgery, brachytherapy, or proton therapy were excluded.
• Matching was performed to eliminate confounding variables via PSM. Simple 1–1 nearest neighbor matching resulted in a matched sample of 5,430 (2,715 in each group).
Propensity Score Matched Comparison of Intensity Modulated Radiation Therapy vs Stereotactic Body Radiation Therapy for
Localized Prostate Cancer: A Survival Analysis form the National Cancer Database
Anthony Ricco, Alexandra Hanlon and Rachelle Lanciano
![Page 42: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/42.jpg)
Philadelphia CyberKnife: NCBD
Ricco et al, Front. Oncol. August 2017
![Page 43: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/43.jpg)
Philadelphia CyberKnife: NCBD
Ricco et al, Front. Oncol. August 2017
![Page 44: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/44.jpg)
Philadelphia CyberKnife: NCDB
Ricco et al, Front. Oncol. August 2017
![Page 45: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/45.jpg)
Philadelphia CyberKnife: NCDB
Ricco et al, Front. Oncol. August 2017
![Page 46: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/46.jpg)
Philadelphia CyberKnife: NCDB
Ricco et al, Front. Oncol. August 2017
![Page 47: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/47.jpg)
Ongoing Trials
![Page 48: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/48.jpg)
CyberKnife® SBRT for Localized Prostate Cancer: Summary
• Excellent outcomes from published data– Similar to existing techniques
• Short duration– Opportunity cost
• Dose escalation compared to conventional fractionation
• Low toxicity profile with excellent QOL outcomes• Lower health care costs
![Page 49: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/49.jpg)
Conclusion
• CyberKnife® Prostate SBRT offers an excellent radiation therapy alternative to existing techniques.
• The increased convenience, cost-effectiveness and unique radiobiology of prostate cancer offer advantages compared to existing treatment platforms.
• Clinical outcomes are at least equivalent compared to existing techniques.
![Page 50: CYBERKNIFE SBRT FOR THE TREATMENT OF ......CYBERKNIFE SBRT FOR THE TREATMENT OF PROSTATE CANCER: 5 VS. 44 FRACTIONS THE PHILADELPHIA CYBERKNIFE CENTER EXPERIENCE Olusola Obayomi -Davies](https://reader030.vdocument.in/reader030/viewer/2022040306/5ec555f613b08355f20a9aa0/html5/thumbnails/50.jpg)